Tetraspanin CD9 Is a “Proteolipid,” and Its Interaction with α3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell Motility*

GM3 ganglioside inhibits tetraspanin CD9-facilitated cell motility in various cell lines (Ono, M., Handa, K., Sonnino, S., Withers, D. A., Nagai, H., and Hakomori, S. (2001) Biochemistry 40, 6414–6421). We now report the following: (i) CD9 has the novel feature of being soluble in chloroform/methanol, and classifiable as “proteolipid”; (ii) CD9 and α3 integrin were concentrated together in the low-density glycolipid-enriched microdomain (GEM) of ldlD/CD9 cells, and the α3 expression ratio (value for cells grown under +Gal condition divided by the value for cells grown under −Gal condition) in GEM of ldlD/CD9 cells was higher than that in control ldlD/moc cells, suggesting that CD9 recruits α3 in GEM under +Gal condition, whereby GM3 is present. (iii) Chemical levels of α3 and CD9 in the total extract or membrane fractions from cells grown under +Gal versus −Gal condition were nearly identical, whereas α3 expressed at the cell surface, probed by antibody binding in flow cytometry, was higher under −Gal than +Gal condition. These results suggest that GM3 synthesized under +Gal condition promotes interaction of α3 with CD9, which restricts α3 binding to its antibody. A concept of the α3/CD9 interaction promoted by GM3 was further supported by (i) co-immunoprecipitation of CD9 and α3under +Gal but not −Gal condition, (ii) enhanced co-immunoprecipitation of CD9 and α3 when GM3 was added exogenously to cells under −Gal condition, and (iii) the co-localization images of CD9 with α3 and of GM3 with CD9 in fluorescence laser scanning confocal microscopy. Based on the promotion of α3/CD9 interaction by GM3 and the status of laminin-5 as a true ligand for α3, the laminin-5/α3-dependent motility of ldlD/CD9 cells was found to be greatly enhanced under −Gal condition, but strongly inhibited under +Gal condition. Such a motility difference under +Gal versus −Gal condition was not observed for ldlD/moc cells. The inhibitory effect observed in ldlD/CD9 cells under +Gal condition was reversed upon addition of anti-α3antibody and is therefore based on interaction between α3, CD9, and GM3 in GEM.

[1]  M. Hemler,et al.  Specific tetraspanin functions , 2001, The Journal of cell biology.

[2]  F. Berditchevski Complexes of tetraspanins with integrins: more than meets the eye. , 2001, Journal of cell science.

[3]  K. Handa,et al.  Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells. , 2001, International journal of oncology.

[4]  K. Handa,et al.  GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. , 2001, Biochemistry.

[5]  S. Hanash,et al.  The Major CD9 and CD81 Molecular Partner , 2001, The Journal of Biological Chemistry.

[6]  K. Handa,et al.  Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. , 2000, Biochemical and biophysical research communications.

[7]  K. Handa,et al.  Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM. , 2000, Biochemical and biophysical research communications.

[8]  D. Azorsa,et al.  Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. , 1999, The Biochemical journal.

[9]  K. Handa,et al.  Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. , 1999, Cancer research.

[10]  K. Iwabuchi,et al.  Separation of “Glycosphingolipid Signaling Domain” from Caveolin-containing Membrane Fraction in Mouse Melanoma B16 Cells and Its Role in Cell Adhesion Coupled with Signaling* , 1998, The Journal of Biological Chemistry.

[11]  C. Boucheix,et al.  CD19 Is Linked to the Integrin-associated Tetraspans CD9, CD81, and CD82* , 1998, The Journal of Biological Chemistry.

[12]  M. Hemler Integrin associated proteins. , 1998, Current opinion in cell biology.

[13]  K. Iwabuchi,et al.  GM3-enriched Microdomain Involved in Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Mouse Melanoma B16 Cells* , 1998, The Journal of Biological Chemistry.

[14]  K. Handa,et al.  A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note. , 1997, Biochemical and biophysical research communications.

[15]  B. Sordat,et al.  Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. , 1997, Cancer research.

[16]  C. Peschle,et al.  Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. , 1997, Journal of lipid research.

[17]  S. Levy,et al.  The tetraspanin superfamily: molecular facilitators , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  S. Yamagata,et al.  Inhibition of highly metastatic FBJ-LL cell migration by ganglioside GD1a highly expressed in poorly metastatic FBJ-S1 cells. , 1997, Biochemical and biophysical research communications.

[19]  W. Rodgers,et al.  Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains , 1996, The Journal of cell biology.

[20]  Y. Miyagi,et al.  Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. , 1996, Journal of biochemistry.

[21]  F. Berditchevski,et al.  Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). , 1996, Journal of immunology.

[22]  W. Carter,et al.  Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein , 1996, The Journal of cell biology.

[23]  M. Adachi,et al.  Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. , 1995, Cancer research.

[24]  D. Brown,et al.  Triton X-100-resistant membrane complexes from cultured kidney epithelial cells contain the Src family protein tyrosine kinase p62yes. , 1994, The Journal of biological chemistry.

[25]  S. Hakomori,et al.  Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. , 1994, The Journal of biological chemistry.

[26]  Y. Kikkawa,et al.  A large cell-adhesive scatter factor secreted by human gastric carcinoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Weitzman,et al.  The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. , 1993, The Journal of biological chemistry.

[28]  T. Sasaki,et al.  Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. , 1993, The Journal of biological chemistry.

[29]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[30]  M. Seno,et al.  Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility , 1991, The Journal of experimental medicine.

[31]  W. Carter,et al.  Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes , 1991, Cell.

[32]  S. Hakomori,et al.  A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. , 1991, Biochemistry.

[33]  M. Hendrix,et al.  Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. , 1989, Cancer research.

[34]  S. Hakomori,et al.  An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. , 1988, Cancer research.

[35]  K. Yamada,et al.  Biosynthesis and acquisition of biological activity of the fibronectin receptor. , 1987, The Journal of biological chemistry.

[36]  C. Ewing,et al.  The erasable Western blot. , 1987, Analytical biochemistry.

[37]  W. Stoffel,et al.  Individual exons encode the integral membrane domains of human myelin proteolipid protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Kingsley,et al.  Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal UDP-GalNAc 4-epimerase deficient mutant , 1986, Cell.

[39]  M. Tagawa,et al.  Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma. , 1985, The Journal of biological chemistry.

[40]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[41]  W. Carter,et al.  A new cell surface, detergent-insoluble glycoprotein matrix of human and hamster fibroblasts. The role of disulfide bonds in stabilization of the matrix. , 1981, The Journal of biological chemistry.

[42]  J. Folch,et al.  Isolation of brain strandin, a new type of large molecule tissue component. , 1951, The Journal of biological chemistry.

[43]  J. Folch,et al.  Proteolipides, a new type of tissue lipoproteins; their isolation from brain. , 1951, The Journal of biological chemistry.

[44]  R. G. Anderson The caveolae membrane system. , 1998, Annual review of biochemistry.

[45]  D. Kingsley,et al.  Analysis of the synthesis, intracellular sorting, and function of glycoproteins using a mammalian cell mutant with reversible glycosylation defects. , 1989, Methods in cell biology.